메뉴 건너뛰기




Volumn 31, Issue 1-3, 2002, Pages 123-128

The specificity of amylin for the diagnosis of pancreatic adenocarcinoma

Author keywords

Amylin; Diagnosis; Pancreatic cancer; Tumor marker

Indexed keywords

AMYLIN; BIOLOGICAL MARKER; TUMOR MARKER;

EID: 0036938058     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:31:1-3:123     Document Type: Article
Times cited : (9)

References (16)
  • 2
    • 0029002348 scopus 로고
    • Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients
    • Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-731.
    • (1995) Ann Surg , vol.221 , pp. 721-731
    • Yeo, C.J.1    Cameron, J.L.2    Lillemoe, K.D.3
  • 3
    • 0032111677 scopus 로고    scopus 로고
    • Imaging techniques in the evaluation of adenocarcinoma of the pancreas
    • Brand RE, Matamoros A. Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 1998;16:242-252.
    • (1998) Dig Dis , vol.16 , pp. 242-252
    • Brand, R.E.1    Matamoros, A.2
  • 4
    • 0018214433 scopus 로고
    • A prospective study of glucose tolerance, insulin, C-peptide and glucagon responses in patients with pancreatic carcinoma
    • Schwarz SS, Zeidler A, Moossa AR, et al. A prospective study of glucose tolerance, insulin, C-peptide and glucagon responses in patients with pancreatic carcinoma. Dig Dis Sci 1978;23:1107-1114.
    • (1978) Dig Dis Sci , vol.23 , pp. 1107-1114
    • Schwarz, S.S.1    Zeidler, A.2    Moossa, A.R.3
  • 5
    • 0027521023 scopus 로고
    • Pancreatic cancer is associated with impaired glucose metabolism
    • Permert J, Ihse I, Jorfeldt L, et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-107.
    • (1993) Eur J Surg , vol.159 , pp. 101-107
    • Permert, J.1    Ihse, I.2    Jorfeldt, L.3
  • 6
    • 0028054783 scopus 로고
    • Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
    • Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Eng J Med 1994;330:313-318.
    • (1994) N Eng J Med , vol.330 , pp. 313-318
    • Permert, J.1    Larsson, J.2    Westermark, G.T.3
  • 7
    • 0027538119 scopus 로고
    • Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors
    • Bretherton-Watt D, Ghatei MA, Bloom SE, et al. Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors. J Clin Endocrinol Metab 1993;76:1072-1074.
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 1072-1074
    • Bretherton-Watt, D.1    Ghatei, M.A.2    Bloom, S.E.3
  • 8
    • 0025287442 scopus 로고
    • Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans
    • Butler PC, Chou J, Carter WB, et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990;39:752-756.
    • (1990) Diabetes , vol.39 , pp. 752-756
    • Butler, P.C.1    Chou, J.2    Carter, W.B.3
  • 9
    • 0025967810 scopus 로고
    • Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients
    • Sanke T, Hanabusa T, Nakano Y, et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:129-132.
    • (1991) Diabetologia , vol.34 , pp. 129-132
    • Sanke, T.1    Hanabusa, T.2    Nakano, Y.3
  • 10
    • 0025957988 scopus 로고
    • Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin
    • Hartter E, Svoboda T, Ludvik B, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin. Diabetologia 1991;34:52-54.
    • (1991) Diabetologia , vol.34 , pp. 52-54
    • Hartter, E.1    Svoboda, T.2    Ludvik, B.3
  • 11
    • 0026595151 scopus 로고
    • Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus
    • Eriksson J, Nakazato M, Miyazato M, et al. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:291-293.
    • (1992) Diabetologia , vol.35 , pp. 291-293
    • Eriksson, J.1    Nakazato, M.2    Miyazato, M.3
  • 13
    • 0034837496 scopus 로고    scopus 로고
    • Sensitivity and specificity of CA 19-9 and islet amyloid polypeptide (IAPP) for symptomatic pancreatic cancer (PC). Abstract for American Pancreatic Association Mtg 1998
    • Chari S, Klee GG, Miller LJ, et al. Sensitivity and specificity of CA 19-9 and islet amyloid polypeptide (IAPP) for symptomatic pancreatic cancer (PC). Abstract for American Pancreatic Association Mtg 1998. Gastroenterology 2001;121:640-645.
    • (2001) Gastroenterology , vol.121 , pp. 640-645
    • Chari, S.1    Klee, G.G.2    Miller, L.J.3
  • 14
    • 0026513764 scopus 로고
    • Diagnosis of pancreatic carcinoma
    • Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Pancreas 1992;7:66-86.
    • (1992) Pancreas , vol.7 , pp. 66-86
    • Niederau, C.1    Grendell, J.H.2
  • 15
    • 0025307965 scopus 로고
    • The clinical utility of the CA 19-9 tumor-associated antigen
    • Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-355.
    • (1990) Am J Gastroenterol , vol.85 , pp. 350-355
    • Steinberg, W.1
  • 16
    • 0028294001 scopus 로고
    • Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma
    • Kondo H, Sugano K, Fukayama N, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-1594.
    • (1994) Cancer , vol.73 , pp. 1589-1594
    • Kondo, H.1    Sugano, K.2    Fukayama, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.